Pancreatic Cancer Research

ResearcherPeking UniversityNo recent work listed

Jun Zhan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6034-840X; OpenAlex author ID A5003230170. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 5

  1. Acetylated HOXB9 at lysine 27 is of differential diagnostic value in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11684-019-0696-6↗
  2. G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.2147/cmar.s165226↗
  3. High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.2147/ott.s111382↗
  4. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9. Co-author DOI 10.1016/j.canlet.2015.02.039↗
  5. Integrin αvβ₆-Targeted SPECT Imaging for Pancreatic Cancer Detection. Co-author DOI 10.2967/jnumed.113.132969↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongquan Zhang · 4 shared papers, 2014–2020 · strength 0.29
  2. Lingfu Zhang · 2 shared papers, 2016–2018 · strength 0.15
  3. Xiaoran Sun · 1 shared paper, 2020 · strength 0.13
  4. Dianrong Xiu · 1 shared paper, 2018 · strength 0.09
  5. Chunhui Yuan · 1 shared paper, 2018 · strength 0.09
  6. Lianyuan Tao · 1 shared paper, 2018 · strength 0.09
  7. Bin Jiang · 1 shared paper, 2018 · strength 0.09
  8. Dianrong Xiu · 1 shared paper, 2016 · strength 0.06
  9. Zhaofei Liu · 1 shared paper, 2014 · strength 0.04
  10. Zhaohui Zhu · 1 shared paper, 2014 · strength 0.04
  11. Fan Wang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.